Methamphetamine-Associated Psychosis

Extended access to methamphetamine self-administration affects sensorimotor gating in rats

(2010) Martin Hadamitzky et al.   BEHAVIOURAL BRAIN RESEARCH

Antipsychotic Medication: The Potential Role of 5-HT1A Receptor Agonism

(2010) Andrew McCreary et al.   CURRENT PHARMACEUTICAL DESIGN

Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders

(2010) R. Lee Mosley et al.   EXPERIMENTAL NEUROLOGY

PROKR2 is associated with methamphetamine dependence in the Japanese population

(2010) Taro Kishi et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Aripiprazole attenuates established behavioral sensitization induced by methamphetamine

(2010) Takashi Futamura et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population

(2010) Tomoko Tsunoka et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

High dose D-serine in the treatment of schizophrenia

(2010) Joshua T. Kantrowitz et al.   SCHIZOPHRENIA RESEARCH

Short Allele of 5-HTTLPR as a Risk Factor for the Development of Psychosis in Japanese Methamphetamine Abusers

(2009) Norikazu Ezaki et al.   Annals of the New York Academy of Sciences

Association Study of the Calcineurin A Gamma Subunit Gene (PPP3CC) and Methamphetamine-Use Disorder in a Japanese Population

(2009) Y. Kinoshita et al.   Annals of the New York Academy of Sciences

Association Study betweenCasein Kinase 1 EpsilonGene and Methamphetamine Dependence

(2009) T. Kotaka et al.   Annals of the New York Academy of Sciences

Prostate Apoptosis Response 4 Gene Is Not Associated with Methamphetamine-Use Disorder in the Japanese Population

(2009) Taro Kishi et al.   Annals of the New York Academy of Sciences

Dopamine Disposition in the Presynaptic Process Regulates the Severity of Methamphetamine-Induced Neurotoxicity

(2009) Donald M. Kuhn et al.   Annals of the New York Academy of Sciences

Innate and Adaptive Immunity for the Pathobiology of Parkinson's Disease

(2009) David K. Stone et al.   ANTIOXIDANTS & REDOX SIGNALING

Methamphetamine toxicity and messengers of death

(2009) Irina N. Krasnova et al.   BRAIN RESEARCH REVIEWS

Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis

(2009) Taro Kishi et al.   JOURNAL OF HUMAN GENETICS

Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients

(2009) Taro Kishi et al.   NEUROPHARMACOLOGY

Human Methamphetamine Pharmacokinetics Simulated in the Rat: Behavioral and Neurochemical Effects of a 72-h Binge

(2009) Ronald Kuczenski et al.   NEUROPSYCHOPHARMACOLOGY

Reversal-Specific Learning Impairments After a Binge Regimen of Methamphetamine in Rats: Possible Involvement of Striatal Dopamine

(2009) Alicia Izquierdo et al.   NEUROPSYCHOPHARMACOLOGY

An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis

(2009) Kazuhiko Nakamura et al.   NEUROSCIENCE LETTERS

G72 gene is associated with susceptibility to methamphetamine psychosis

(2009) Tatsuya Kotaka et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population

(2009) Tomo Okochi et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis

(2009) Taro Kishi et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis

(2009) Hiroshi Ujike et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Genome-wide parametric linkage analyses of 644 bipolar pedigrees suggest susceptibility loci at chromosomes 16 and 20

(2009) Jessica Ross et al.   PSYCHIATRIC GENETICS

Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence

(2009) Yuko Okahisa et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: involvement of pallidotegmental neurons

(2009) Hiroyuki Mizoguchi et al.   PSYCHOPHARMACOLOGY

Association study between thePIK4CAgene and methamphetamine use disorder in a Japanese population

(2008) Nobuhisa Kanahara et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

The Frizzled 3 gene is associated with methamphetamine psychosis in the Japanese population

(2008) Makiko Kishimoto et al.   Behavioral and Brain Functions

Novel Linkage to Chromosome 20p Using Latent Classes of Psychotic Illness in 270 Irish High-Density Families

(2008) Ayman H. Fanous et al.   BIOLOGICAL PSYCHIATRY

GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice

(2008) Sawako Arai et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia

(2008) Cynthia Shannon Weickert et al.   HUMAN MOLECULAR GENETICS

Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling

(2008) David M. Thomas et al.   JOURNAL OF NEUROCHEMISTRY

The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity

(2008) David M. Thomas et al.   JOURNAL OF NEUROCHEMISTRY

Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia

(2008) PJ Harrison et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Substance Abuse by Youth and Young Adults in Rural America

(2008) David Lambert et al.   JOURNAL OF RURAL HEALTH

Transcriptional regulation at a HTR1A polymorphism associated with mental illness

(2008) Brice Le François et al.   NEUROPHARMACOLOGY

Expression of a GRM3 Splice Variant is Increased in the Dorsolateral Prefrontal Cortex of Individuals Carrying a Schizophrenia Risk SNP

(2008) Leah J Sartorius et al.   NEUROPSYCHOPHARMACOLOGY

Involvement of Pallidotegmental Neurons in Methamphetamine- and MK-801-Induced Impairment of Prepulse Inhibition of the Acoustic Startle Reflex in Mice: Reversal by GABAB Receptor Agonist Baclofen

(2008) Sawako Arai et al.   NEUROPSYCHOPHARMACOLOGY

Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models

(2008) Athina Markou et al.   NEUROPSYCHOPHARMACOLOGY

Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia

(2008) S MAEHARA et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia

(2008) T EDWARDS et al.   SCHIZOPHRENIA RESEARCH

Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex

(2008) Tomohiro Abekawa et al.   SCHIZOPHRENIA RESEARCH

Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice

(2008) Louisa Lyon et al.   SYNAPSE

The Dysbindin Gene (DTNBP1) Is Associated with Methamphetamine Psychosis

(2007) Makiko Kishimoto et al.   BIOLOGICAL PSYCHIATRY

Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse

(2007) Ruth Salo et al.   PSYCHIATRY RESEARCH